Naltrexone
1 NDC across 1 manufacturer|0 Generic,1 Brand
Naltrexone is used to treat alcoholism, drug overdose and opioid-related disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 13, 2006, and the first generic was approved Jul 6, 2023.
Naltrexone is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $1716.48 to $1716.48 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$1716.48 – $1716.48
per EA
7d Activity
avg -0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing NALTREXONE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIVITROL 380 MG VIAL-DILUENT | $1716.4843 per EA | -0.02% |
Frequently Asked Questions
What is Naltrexone used to treat?
Naltrexone is used to treat alcoholism, drug overdose and opioid-related disorders, per the National Library of Medicine's MED-RT classification.
When did Naltrexone become available as a generic?
FDA approved the first generic Naltrexone (ANDA) on Jul 6, 2023.
How many Naltrexone products are on the market?
The Naltrexone drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Naltrexone?
NADAC reference prices for Naltrexone range from $1716.4843 to $1716.4843 per EA.
Which manufacturers make Naltrexone?
1 manufacturer lists Naltrexone in NADAC. Ranked by number of NDCs, the largest are Alkermes, Inc. (1).
How has the price of Naltrexone changed recently?
Over the past 7 days, 0 Naltrexone NDCs rose and 1 fell, with a market-wide average change of -0.0%.